Misfortunes do not come in pairs in patients with active moderate-to-severe Graves' orbitopathy

被引:1
|
作者
Sawicka-Gutaj, Nadia [1 ]
Gruszczynski, Dawid [1 ]
Zawalna, Natalia [1 ]
Nijakowski, Kacper [2 ]
Fichna, Marta [1 ]
Ruchala, Marek [1 ]
机构
[1] Poznan Univ Med Sci, Dept Endocrinol Metab Disorders & Internal Med, Ul Przybyszewskiego 49, PL-60335 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Conservat Dent & Endodont, Poznan, Poland
关键词
EUROPEAN GROUP; ZNT8;
D O I
10.20452/pamw.16773
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves' Orbitopathy
    Yu, Yun
    Hu, Yu-xin
    Lu, Ming-xi
    Ouyang, Zheng-long
    Xu, Ming-tong
    Zhao, Li-yan
    Wang, Mei
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (04) : 1015 - 1024
  • [32] Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves' orbitopathy
    Park, Jungyul
    Kim, Jaehyun
    Kim, Sang Soo
    Choi, Hee-Young
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [33] Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves’ Orbitopathy
    Yun Yu
    Yu-xin Hu
    Ming-xi Lu
    Zheng-long Ouyang
    Ming-tong Xu
    Li-yan Zhao
    Mei Wang
    Ophthalmology and Therapy, 2024, 13 : 1015 - 1024
  • [34] Comparative effectiveness of different treatment modalities for active, moderate-to-severe Graves' orbitopathy: a systematic review and network meta-analysis
    Li, Hongxun
    Yang, Lihong
    Song, Yi
    Zhao, Xinheng
    Sun, Chunhua
    Zhang, Lei
    Zhao, Hong
    Pan, Ye
    ACTA OPHTHALMOLOGICA, 2022, 100 (06) : E1189 - E1198
  • [35] Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO)
    Nowak, Mariusz
    Marek, Bogdan
    Kos-Kudla, Beata
    Sieminska, Lucyna
    Londzin-Olesik, Magdalena
    Glogowska-Szelag, Joanna
    Nowak, Wojciech
    Kajdaniuk, Dariusz
    ENDOKRYNOLOGIA POLSKA, 2022, 73 (04) : 756 - 777
  • [36] Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
    Joanna Rymuza
    Michał Popow
    Zuzanna Żurecka
    Jerzy Przedlacki
    Tomasz Bednarczuk
    Piotr Miśkiewicz
    Endocrine, 2019, 64 : 308 - 315
  • [37] Therapy of moderate-to-severe Graves' orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
    Rymuza, Joanna
    Popow, Michal
    Zurecka, Zuzanna
    Przedlacki, Jerzy
    Bednarczuk, Tomasz
    Miskiewicz, Piotr
    ENDOCRINE, 2019, 64 (02) : 308 - 315
  • [38] Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
    Paolo P. Limone
    Lavinia Bianco
    Marco Mellano
    Francesca Garino
    Fabiana Giannoccaro
    Annalisa Rossi
    Claudia Airaldi
    Daniela Nassisi
    Eva Gino
    Maurilio Deandrea
    Bruno Oldani
    Maria Grazia Ruo Redda
    La radiologia medica, 2021, 126 : 334 - 342
  • [39] Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
    Limone, Paolo P.
    Bianco, Lavinia
    Mellano, Marco
    Garino, Francesca
    Giannoccaro, Fabiana
    Rossi, Annalisa
    Airaldi, Claudia
    Nassisi, Daniela
    Gino, Eva
    Deandrea, Maurilio
    Oldani, Bruno
    Ruo Redda, Maria Grazia
    RADIOLOGIA MEDICA, 2021, 126 (02): : 334 - 342
  • [40] MabThera use and efficacy in patients with active moderate to severe Graves' Orbitopathy: a multicentre retrospective study of 40 cases
    Lebranchu, P.
    Deltour, J. B.
    Cariou, B.
    Vabres, B.
    D'Assigny, M.
    Drui, D.
    ACTA OPHTHALMOLOGICA, 2017, 95